Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets close in 6 hours 29 minutes

S&P 500
6,004.03
+16.66(+0.28%)
Dow 30
44,599.68
-136.89(-0.31%)
Nasdaq
19,137.41
+82.58(+0.43%)
Russell 2000
2,442.03
+35.36(+1.47%)
Crude Oil
69.41
+0.47(+0.68%)
Gold
2,632.80
+14.30(+0.55%)

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.0600

0.0000

(0.00%)

As of 04:00PM EST. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	14.88M
Enterprise Value	18.90M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.41
Price/Book (mrq)	0.60
Enterprise Value/Revenue	0.51
Enterprise Value/EBITDA	106.32

Trading Information

Stock Price History

Beta (5Y Monthly)	0.22
52-Week Change ³	-38.01%
S&P500 52-Week Change ³	31.45%
52 Week High ³	2.3600
52 Week Low ³	1.0400
50-Day Moving Average ³	1.2134
200-Day Moving Average ³	1.5048

Share Statistics

Avg Vol (3 month) ³	38.23k
Avg Vol (10 day) ³	41.88k
Shares Outstanding ⁵	14.04M
Implied Shares Outstanding ⁶	14.3M
Float ⁸	7.83M
% Held by Insiders ¹	44.72%
% Held by Institutions ¹	14.69%
Shares Short (Oct 31, 2024) ⁴	76.74k
Short Ratio (Oct 31, 2024) ⁴	2.31
Short % of Float (Oct 31, 2024) ⁴	0.97%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	0.54%
Shares Short (prior month Sep 30, 2024) ⁴	15.35k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-29.55%
Operating Margin (ttm)	-18.65%

Management Effectiveness

Return on Assets (ttm)	-5.64%
Return on Equity (ttm)	-36.07%

Income Statement

Revenue (ttm)	36.79M
Revenue Per Share (ttm)	2.61
Quarterly Revenue Growth (yoy)	-9.90%
Gross Profit (ttm)	N/A
EBITDA	-2.79M
Net Income Avi to Common (ttm)	-10.87M
Diluted EPS (ttm)	-0.7600
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	17.46M
Total Cash Per Share (mrq)	1.25
Total Debt (mrq)	21.48M
Total Debt/Equity (mrq)	87.79%
Current Ratio (mrq)	1.13
Book Value Per Share (mrq)	1.77

Cash Flow Statement

Operating Cash Flow (ttm)	-1.48M
Levered Free Cash Flow (ttm)	3.91M